跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Combizar - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Combizar
Approved
STANDARD
Combizar
Amherst Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
638ab3e6411edbc4
Company
Amherst Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
638ab3e6411edbc4
Drug Approval Philippines Name
Combizar
Product Name
Combizar
Registration Number
DRP-3753
Brand Name
Combizar
Generic Name
Losartan Potassium + Hydrochlorothiazide
Dosage Form
Tablet
Dosage Strength
50 mg/12.5 mg
Manufacturer
Amherst Laboratories, Inc.
Trader
UNILAB, Inc.
Issuance Date
24 March 2022
Expiry Date
28 August 2027
Pharmacologic Category
Angiotensin II Receptor Blocker / Diuretic
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
638ab3e6411edbc4
Type
Standard
Back to Philippines FDA Approvals